GO:0016922 nuclear receptor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016922 nuclear receptor binding is a molecular function describing the binding of a protein to a nuclear receptor, a DNA-binding transcription factor regulated by ligand binding.
• Nuclear receptor binding is mediated by coactivator and coregulator proteins that often contain LXXLL-like interaction motifs and recruit histone-modifying enzymes.
• The function is central to ligand-dependent transcriptional regulation in development, metabolism, circadian biology and disease.
• Key experimental models include knockout, point-mutation, knock-in and overexpression cell lines, combined with interaction and transcriptomic assays.
• Dysregulation of nuclear receptor binding is linked to cancer, metabolic disease and circadian disruption.
• CRISPR-based screening and bioinformatics can systematically map nuclear receptor interaction networks and their downstream targets.
Description
GO:0016922 nuclear receptor binding is a molecular function defined as binding to a nuclear receptor protein. Nuclear receptors are DNA-binding transcription factors whose activity is regulated by ligand binding, and they control gene expression programs in development, metabolism and homeostasis. This function is typically executed by coregulator proteins that physically associate with nuclear receptors and modulate their transcriptional output. Because nuclear receptor signaling is ligand-dependent, the binding event is a key point of regulation and a frequent target of pharmacological intervention. Researchers study nuclear receptor binding to understand how hormones, metabolites and xenobiotics reprogram gene expression, and to identify therapeutic opportunities in cancer, metabolic disease and circadian disorders. The function is experimentally tractable: interaction domains, cofactor requirements and downstream transcriptional consequences can be dissected with modern CRISPR models and multi-omics methods.
nuclear receptor binding At A Glance
| GO ID | GO:0016922 |
|---|---|
| GO term | nuclear receptor binding |
| Ontology | molecular_function |
| Synonym | ligand-dependent nuclear receptor binding; ligand-dependent nuclear receptor interactor activity; nuclear hormone receptor binding; steroid hormone receptor binding |
| Definition | Binding to a nuclear receptor protein. Nuclear receptor proteins are DNA-binding transcription factors which are regulated by binding to a ligand. |
| Major function | Protein-protein interaction that recruits coregulators and modulates nuclear receptor transcriptional activity |
| Biological context | Ligand-dependent transcription, development, metabolism, circadian regulation |
| Representative interactors | Coactivators such as NCOA proteins, CBP/p300, ASC-2 and other coregulators |
| Disease relevance | Cancer, metabolic disorders and circadian disruption |
What Is GO:0016922?
In your own words, GO:0016922 nuclear receptor binding describes the selective, non-covalent interaction of a protein with a nuclear receptor. The nuclear receptor partner is a DNA-binding transcription factor whose activity is controlled by ligand binding, so the binding event often occurs in a ligand-dependent manner. This function is distinct from DNA binding itself: it is the protein-protein recognition step that allows coregulators, chaperones or signaling proteins to dock onto nuclear receptors and influence their transcriptional activity.
Why Is nuclear receptor binding Important in Cell Biology?
Nuclear receptor binding is important because it converts a ligand signal into a transcriptional response. Nuclear receptors are DNA-binding transcription factors regulated by ligands, and their ability to activate or repress target genes depends on the recruitment of binding partners. This function therefore sits at the interface between endocrine signaling, metabolism and gene regulation, and it is a recurring node in diseases such as cancer and metabolic syndrome. Understanding nuclear receptor binding also informs drug discovery, because many therapeutic strategies aim to modulate coregulator recruitment rather than ligand binding itself.
• Controls ligand-dependent transcription by recruiting coactivators and corepressors to nuclear receptors.
• Shapes developmental and metabolic gene programs through nuclear receptor signaling.
• Contributes to circadian regulation and feeding-related physiology.
• Provides a mechanistic basis for endocrine and metabolic disease.
• Is a target for pharmacological modulation of nuclear receptor activity.
• Can be mapped systematically with interaction proteomics and CRISPR screens.
• Involves structurally diverse interaction surfaces across the nuclear receptor superfamily.
• Links ligand sensing to chromatin modification and transcriptional output.
What Happens During nuclear receptor binding?
Ligand-dependent activation of the nuclear receptor
In simple terms: A hormone or metabolite binds the nuclear receptor and changes its shape so it can recruit partner proteins.
Nuclear receptors are DNA-binding transcription factors regulated by ligand binding. Ligand binding induces conformational changes that create or expose interaction surfaces for coregulator proteins, thereby converting a chemical signal into a protein-protein binding event. This step is the prerequisite for the recruitment of coactivators and for downstream transcriptional activation.
Recruitment of coactivators and coregulators
In simple terms: Partner proteins dock onto the activated receptor and help turn genes on or off.
Once activated, nuclear receptors recruit coactivator proteins that often contain interaction domains such as LXXLL-like motifs. These coactivators can include CBP/p300 and ASC-2, which provide a bridge to the general transcriptional machinery and to chromatin-modifying activities. The binding event is therefore a central step in assembling a functional transcription complex.
Chromatin modification and transcriptional output
In simple terms: The recruited proteins modify chromatin and switch target genes on or off.
Coactivators recruited through nuclear receptor binding frequently possess histone acetyltransferase or other chromatin-modifying activities that alter the local chromatin environment. This leads to changes in target gene expression that underlie developmental, metabolic and homeostatic programs. The specificity of the response depends on which nuclear receptor and which coregulator are engaged.
Integration with other signaling and regulatory layers
In simple terms: Nuclear receptor binding does not act alone; it is integrated with other cellular signals.
Nuclear receptor binding can be modulated by post-translational modifications, by the availability of ligands and by interactions with other signaling pathways. For example, nuclear receptor RXRα can bind the precursor of miR-103 and influence its maturation, illustrating that nuclear receptor interactions extend beyond classical transcription. Circadian and feeding-related regulation also intersect with nuclear receptor signaling.
Key Genes Involved in GO:0016922 nuclear receptor binding
The following genes and proteins are representative participants in nuclear receptor binding, based on published studies of nuclear receptor coregulators and interacting factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NCOA1 | Nuclear receptor coactivator that binds activated receptors | Model for coactivator recruitment and transcriptional activation |
| NCOA2 | Nuclear receptor coactivator with LXXLL interaction motifs | Studied for ligand-dependent binding and gene regulation |
| NCOA3 | Coactivator that enhances nuclear receptor transactivation | Relevant to cancer and metabolic gene programs |
| CREBBP | Histone acetyltransferase recruited by nuclear receptors | Links nuclear receptor binding to chromatin modification |
| EP300 | Histone acetyltransferase and transcriptional coactivator | Used to study coactivator-dependent transcription |
| NCOA6 | Activating signal cointegrator-2 (ASC-2) family coactivator | Contains distinct nuclear receptor-interaction domains |
| NR0B1 | Orphan nuclear receptor and coregulator | Model for interaction domain studies |
| NR1H4 | FXR, bile acid receptor and biological sensor | Links ligand sensing to nuclear receptor binding |
| RXRA | Retinoid X receptor alpha, heterodimer partner | Binds miR-103 precursor and regulates maturation |
| NR4A1 | Orphan nuclear receptor NGFI-B | Studied for DNA-binding and interaction mechanisms |
| NCOR1 | Nuclear receptor corepressor | Model for negative regulation of nuclear receptor activity |
| NCOR2 | Corepressor that binds nuclear receptors | Studied in transcriptional repression |
| MED1 | Mediator subunit interacting with nuclear receptors | Links nuclear receptor binding to transcription initiation |
| KAT2B | Histone acetyltransferase coactivator | Used in chromatin and transcription studies |
| TADA3 | Transcriptional adaptor and coactivator component | Relevant to nuclear receptor-dependent activation |
| TRIP10 | Nuclear receptor-interacting protein | Model for interaction domain mapping |
| PPARGC1A | Transcriptional coactivator for nuclear receptors | Studied in metabolic gene regulation |
How Is nuclear receptor binding Regulated?
Nuclear receptor binding is regulated at multiple levels. Ligand availability controls the conformational state of the receptor and thus its ability to recruit coregulators. Post-translational modifications of both the receptor and its binding partners can strengthen or weaken interactions. In addition, the abundance and competition among coactivators and corepressors determine the transcriptional outcome. Physiological states such as feeding and circadian timing can also influence nuclear receptor signaling and its interaction network. Finally, non-coding RNA interactions, such as RXRα binding to the miR-103 precursor, add an additional layer of regulation.
nuclear receptor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NCOA1 | Hormone-dependent cancer | Knockout and overexpression cell lines |
| NCOA2 | Metabolic and endocrine disorders | Point-mutation models of interaction motifs |
| NR1H4 | Bile acid and metabolic disease | Knockout and ligand-response assays |
| RXRA | Cancer and RNA maturation defects | Knock-in and interaction assays |
| NCOR1 | Transcriptional repression in disease | Knockout and rescue models |
Cancer
Nuclear receptor binding and coregulator recruitment are frequently altered in cancer, where changes in coactivator or corepressor activity can drive hormone-dependent tumor growth. Because nuclear receptors are ligand-regulated transcription factors, therapeutic strategies often target the interaction interface or the downstream transcriptional program.
Metabolic disease
Nuclear receptors such as FXR function as metabolic sensors, and their binding partners influence bile acid, lipid and glucose homeostasis. Disruption of these interactions can contribute to metabolic dysfunction, making nuclear receptor binding a relevant area for metabolic disease research.
Circadian and feeding-related disorders
Circadian oscillators in peripheral tissues can be uncoupled from the central pacemaker by restricted feeding, and nuclear receptor signaling intersects with these pathways. This link suggests that nuclear receptor binding contributes to the metabolic and circadian misalignment observed in shift work and eating disorders.
From nuclear receptor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a coactivator affect nuclear receptor target genes? | Knockout cell line plus RNA-seq |
| Which residues mediate receptor-coregulator binding? | Point-mutation knock-in of interaction motifs |
| Can a tagged receptor capture dynamic interactors? | Tagged knock-in with affinity proteomics |
| Does overexpression of a coactivator drive transformation? | Overexpression cell model |
| Which nuclear receptor interactions are ligand-dependent? | Ligand-treatment interaction assays |
| How does RXRα interact with non-coding RNA? | Knock-in and RNA interaction assays |
How to Study the nuclear receptor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between proteins | Validate nuclear receptor binding |
| Mass spectrometry | Protein complex composition | Map coregulator networks |
| RNA-seq | Transcriptional changes | Identify target genes after knockout |
| CRISPR screen | Gene requirement in a phenotype | Discover nuclear receptor regulators |
| Luciferase reporter | Transcriptional activity | Test ligand-dependent activation |
| FRET/BRET | Real-time interaction dynamics | Measure binding in live cells |
| ChIP-seq | Chromatin occupancy | Link binding to DNA regulatory elements |
| Proximity labeling | Spatial interactome | Capture transient interactions |
Interaction proteomics
Affinity purification coupled to mass spectrometry can identify proteins that bind nuclear receptors under different ligand conditions. This approach maps the nuclear receptor interactome and reveals coactivator and corepressor complexes.
Transcriptomic profiling
RNA-seq after knockout or point mutation of nuclear receptor binding partners reveals downstream target gene programs. This connects the binding event to transcriptional output and disease-relevant pathways.
CRISPR screening
Pooled CRISPR screens can identify genes required for nuclear receptor-dependent transcription or for ligand responses. Such screens help prioritize coregulators and interaction factors for follow-up.
Imaging and reporter assays
Fluorescence imaging and luciferase reporters can visualize nuclear receptor localization and transcriptional activity in live cells. These methods are useful for validating binding-dependent effects.
How CRISPR Can Be Used to Study GO:0016922 nuclear receptor binding
Knockout
CRISPR knockout of coactivator or corepressor genes can test whether nuclear receptor binding is required for target gene expression and cellular phenotypes. Knockout models are also used to validate hits from interaction proteomics or CRISPR screens.
Point Mutation
Point mutations in interaction motifs, such as LXXLL-like sequences, can disrupt nuclear receptor binding while preserving protein expression. These models are valuable for separating binding-dependent from binding-independent functions.
Knock-in
Knock-in of epitope tags or fluorescent tags at endogenous loci enables tracking of nuclear receptor binding partners in their native context. Tagged knock-in models support affinity purification and imaging studies.
Overexpression
Overexpression of nuclear receptors or their coactivators can amplify ligand-dependent transcriptional responses and reveal gain-of-function phenotypes. Such models are useful for testing whether increased binding drives disease-relevant gene programs.
How EDITGENE Supports nuclear receptor binding Research
Researchers studying nuclear receptor binding-related genes often need to determine whether a candidate gene is causally involved in ligand-dependent transcription, whether a specific interaction motif is required, and how the binding event shapes downstream gene expression. EDITGENE provides the CRISPR cell models and screening services needed to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for nuclear receptor binding research.
Frequently Asked Questions About nuclear receptor binding
What is GO:0016922 nuclear receptor binding?
GO:0016922 is a molecular function describing the binding of a protein to a nuclear receptor, which is a DNA-binding transcription factor regulated by ligand binding.
What genes are involved in nuclear receptor binding?
Representative genes include NCOA1, NCOA2, NCOA3, CREBBP, EP300, NCOA6, NCOR1, NCOR2 and RXRA, among others.
Why is nuclear receptor binding important?
It converts ligand signals into transcriptional responses by recruiting coregulators and chromatin-modifying enzymes to nuclear receptors.
What diseases are linked to nuclear receptor binding?
Cancer, metabolic disease and circadian or feeding-related disorders have been linked to nuclear receptor signaling and coregulator function.
How can I study nuclear receptor binding in the lab?
Common methods include co-immunoprecipitation, mass spectrometry, RNA-seq, CRISPR screens and reporter assays.
What is the role of coactivators in nuclear receptor binding?
Coactivators dock onto activated nuclear receptors and recruit transcriptional machinery and chromatin modifiers.
Can CRISPR be used to study nuclear receptor binding?
Yes, knockout, point-mutation, knock-in and overexpression models can dissect the function of nuclear receptor binding partners.
What is the difference between nuclear receptor binding and DNA binding?
Nuclear receptor binding is a protein-protein interaction, whereas DNA binding refers to the receptor's direct contact with DNA response elements.
Which nuclear receptor interacts with miR-103 precursor?
RXRα has been reported to bind the precursor of miR-103 and inhibit its maturation.
How does ligand binding affect nuclear receptor interactions?
Ligand binding changes receptor conformation and promotes or destabilizes coregulator interactions, thereby controlling transcription.
Conclusion
GO:0016922 nuclear receptor binding is a central molecular function that links ligand sensing to transcriptional control. It is mediated by coactivators, corepressors and other interacting proteins that dock onto nuclear receptors and shape gene expression programs. Because of its role in cancer, metabolic disease and circadian biology, nuclear receptor binding remains an active area of research. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with interaction proteomics and transcriptomics, provide a powerful toolkit for dissecting this function.
References
- 1. Madaloz TZ et al.. 2023. Nuclear receptor superfamily structural diversity in pacific oyster: In silico identification of estradiol binding candidates.. Chemosphere 340:139877 PMID: 37619748
- 2. Tu H et al.. 2000. FXR, a bile acid receptor and biological sensor.. Trends Cardiovasc Med 10(1):30-5 PMID: 11150726
- 3. Glass CK et al.. 1997. Nuclear receptor coactivators.. Curr Opin Cell Biol 9(2):222-32 PMID: 9069256
- 4. Westin S et al.. 2000. Nuclear receptor coactivators.. Adv Pharmacol 47:89-112 PMID: 10582085
- 5. Lee SK et al.. 2001. Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2.. Mol Endocrinol 15(2):241-54 PMID: 11158331
- 6. Ye X et al.. 2023. Nuclear receptor RXRα binds the precursor of miR-103 to inhibit its maturation.. BMC Biol 21(1):197 PMID: 37735649
- 7. Damiola F et al.. 2000. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus.. Genes Dev 14(23):2950-61 PMID: 11114885
- 8. Meinke G et al.. 1999. DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B.. Nat Struct Biol 6(5):471-7 PMID: 10331876
